Simplifying Global Compliance
FDA Could Give New Guidance on Nanotechnology
Drugmakers will likely see new guidance and consensus standards on nanotechnologies in the near future as the FDA moves forward on its research and regulation of the technologies. The agency also could produce new test methods, publications and presentations as part of its 2011 Nanotechnology Regulatory Science Initiative, Subhas Malghan, deputy director for program policy and evaluation at the Center for Devices and Radiological Health, said at a recent meeting of the FDA’s Science Board.
Washington Drug Letter
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing